Ledger.Open graph →
SEC Form D · Amendment · filed September 21, 2018

X4 Pharmaceuticals, Inc

Offering
$35.0M
Sold
$35.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Paul J. Smith · Gatineau, Quebec, CanadaDirectorSteven Archambault · Gatineau, Quebec, CanadaExec · DirectorHugh J. Notman · Gatineau, Quebec, CanadaExec · DirectorTimothy J. Mccunn · Gatineau, Quebec, CanadaDirectorAdam Mostafa · Cambrdge, MAExecTodd Slattery · New York, NYExec · DirectorDavid Blumer · New York, NYExec · DirectorCathleen Ellsworth · Greenwich, CTDirectorJustin L. Bertram · PITTSBURGH, PADirectorAdam Mostafa · Toronto, Ontario, CanadaExecMichael Wyzga · Redwood City, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗